Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xinjiang Medical UniversityNo recent work listed

Qilong Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5068-6907; OpenAlex author ID A5050147847. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p. Last author DOI 10.1155/2023/6785005↗
  2. miR-146a Inhibited Pancreatic Cancer Cell Proliferation by Targeting SOX7. Last author DOI 10.1155/2022/2240605↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chouman Sulidankazha · 2 shared papers, 2022–2023 · strength 0.39
  2. Hai Lan Lin · 2 shared papers, 2022–2023 · strength 0.39
  3. Tieying He · 2 shared papers, 2022–2023 · strength 0.39
  4. Wei Han · 1 shared paper, 2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.